Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Jun;187(3):605-611.
doi: 10.1007/s10549-021-06264-x. Epub 2021 Jun 2.

Undercutting efforts of precision medicine: roadblocks to minority representation in breast cancer clinical trials

Affiliations
Review

Undercutting efforts of precision medicine: roadblocks to minority representation in breast cancer clinical trials

Geetanjali Saini et al. Breast Cancer Res Treat. 2021 Jun.

Abstract

Precision (or personalized) medicine holds great promise in the treatment of breast cancer. The success of personalized medicine is contingent upon inclusivity and representation for minority groups in clinical trials. In this article, we focus on the roadblocks for the African American demographic, including the barriers to access and enrollment in breast oncology trials, the prevailing classification of race and ethnicity, and the need to refine monolithic categorization by employing genetic ancestry mapping tools for a more accurate determination of race or ethnicity.

Keywords: African Americans; Ancestry informative markers; Oncology trials; Race/ethnicity classification.

PubMed Disclaimer

Similar articles

Cited by

  • Consensus Statements on Precision Oncology in the China Greater Bay Area.
    Lam TC, Cho WC, Au JS, Ma ES, Lam ST, Loong HH, Wong JWH, Wong SNM, Lee VH, Leung RC, Lau JK, Kam MT, Mok FS, Lim FM, Nyaw JS, Tin WW, Cheung KM, Chan OS, Kwong PW, Cheung FY, Poon DMC, Chik JY, Lam MH, Chan LW, Wong SC, Cao YB, Hui CV, Chen JZ, Chang JH, Kong SF, El Helali A; Precision Oncology Working Group (POWG). Lam TC, et al. JCO Precis Oncol. 2023 Jun;7:e2200649. doi: 10.1200/PO.22.00649. JCO Precis Oncol. 2023. PMID: 37315266 Free PMC article.
  • The influence of telehealth-based cancer rehabilitation interventions on disability: a systematic review.
    Brick R, Padgett L, Jones J, Wood KC, Pergolotti M, Marshall TF, Campbell G, Eilers R, Keshavarzi S, Flores AM, Silver JK, Virani A, Livinski AA, Ahmed MF, Kendig T, Khalid B, Barnett J, Borhani A, Bernard G, Lyons KD. Brick R, et al. J Cancer Surviv. 2023 Dec;17(6):1725-1750. doi: 10.1007/s11764-022-01181-4. Epub 2022 Feb 26. J Cancer Surviv. 2023. PMID: 35218521 Free PMC article.

References

    1. Saini G et al (2020) Quadruple-negative breast cancer: an uneven playing field. JCO Glob Oncol 6:233–237 - PubMed
    1. Nazha B et al (2019) Enrollment of racial minorities in clinical trials: old problem assumes new urgency in the age of immunotherapy. Am Soc Clin Oncol Educ Book 39:3–10 - PubMed
    1. Phan VH et al (2009) Ethnic differences in drug metabolism and toxicity from chemotherapy. Expert Opin Drug Metab Toxicol 5(3):243–257 - PubMed
    1. Clements JM et al (2020) Disparities in diabetes-related multiple chronic conditions and mortality: the influence of race. Diabetes Res Clin Pract 159:107984 - PubMed
    1. Zilbermint M et al (2019) Genetics of hypertension in African Americans and others of African descent. Int J Mol Sci 20(5):1081 - PMC

LinkOut - more resources